Are you Dr. Lowery?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 E 66th St
New York, NY 10065Phone+1 646-888-4543
Summary
- Dr. Maeve Lowery, MD is an oncologist in New York, New York. She is currently licensed to practice medicine in New York. She is affiliated with Memorial Sloan Kettering Cancer Center and is an Instructor at Weill Cornell Medical College.
Education & Training
University College of Dublin National Univ SOMClass of 2003
Certifications & Licensure
NY State Medical License 2011 - 2019
Clinical Trials
- First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma Start of enrollment: 2013 Apr 01
- Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer Start of enrollment: 2014 Nov 17
Publications & Presentations
PubMed
- 515 citationsIvosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K. Abou-Alfa, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam J. Lubner
The Lancet. Oncology. 2020-06-01 - 59 citationsPreliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.Jayasree Chakraborty, Liana Langdon-Embry, Kristen M. Cunanan, Joanna G. Escalon, Peter J. Allen
Plos One. 2017-12-07 - 41 citationsPharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic CancerKenneth H. Yu, Mark Ricigliano, Manuel Hidalgo, Ghassan K. Abou-Alfa, Maeve A. Lowery
Clinical Cancer Research. 2014-10-15
Authored Content
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
Press Mentions
Trinity Lead Network of ‘The Best Minds in Ireland' Studying Oesophageal CancerFebruary 9th, 2023- Cancer Conference Zeros in on ResearchNovember 11th, 2022
- Trinity Study Discovers Genetic Mutation Behind Incurable Childhood CancerJuly 22nd, 2021
- Join now to see all
